
New Study Could Improve Precision With Pituitary Tumor Excision
Physicians at the Brigham and Women's Hospital have published results from a proof-of-concept study that used mass spectrometry in almost real-time to detect and delineate pituitary tumors from normal tissue.
Physicians at the Brigham and Women’s Hospital (BWH) have published results from a proof-of-concept study that used mass spectrometry in almost real-time to detect and delineate pituitary tumors from normal tissue. This, the authors claim, can support critical surgical decisions and allow for more precise tumor excision.
Published in the
This would be a big step-up from current methods used to detect hormone levels that are time consuming and force excision of a larger amount of potentially healthy pituitary gland or even follow up surgery if the tumor has not been fully removed.
“Our work is driven by a clinical need: we've developed a test specifically tailored for the needs of our neurosurgeon colleagues,”
Their study, the authors write, supports the inclusion of MALDI MSI in the clinical workflow for the surgical resection of pituitary tumors, potentially allowing for improved surgical precision and patient outcomes. Further studies will evaluate the impact of the technique on clinical decision making.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.